Insurance for Biotechs: Property 3816762268780510832-blid-7751513032903940383

หลวงพี่อุเทนวัดท่าไม้ เตือน2ราศีกรรมเก่าตามเล่นงาน และอีก3ราศีจะรวยพลิกชีวิต

Biotechnology companies and organisations display distinctive features and, from an insurance perspective, uncommon risks. Quite apart from liability risks associated with the testing of investigational drugs, biotech companies are faced with some unique exposures that could delay development, and possibly, the achievement of milestones. Such delays could hamper the ability of the company to raise additional funds and therefore its ability to continue as a going concern.